- Home
- IOBT vs FONR Comparison
IOBT vs FONR Comparison
Compare IOBT & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- FONR
- Stock Information
- Founded
- IOBT 2014
- FONR 1978
- Country
- IOBT Denmark
- FONR United States
- Employees
- IOBT N/A
- FONR N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IOBT Health Care
- FONR Health Care
- Exchange
- IOBT Nasdaq
- FONR Nasdaq
- Market Cap
- IOBT 114.6M
- FONR 100.6M
- IPO Year
- IOBT 2021
- FONR 1987
- Fundamental
- Price
- IOBT $1.62
- FONR $15.51
- Analyst Decision
- IOBT Strong Buy
- FONR
- Analyst Count
- IOBT 2
- FONR 0
- Target Price
- IOBT $8.00
- FONR N/A
- AVG Volume (30 Days)
- IOBT 1.1M
- FONR 10.0K
- Earning Date
- IOBT 11-11-2025
- FONR 09-12-2025
- Dividend Yield
- IOBT N/A
- FONR N/A
- EPS Growth
- IOBT N/A
- FONR N/A
- EPS
- IOBT N/A
- FONR 1.21
- Revenue
- IOBT N/A
- FONR $104,351,318.00
- Revenue This Year
- IOBT N/A
- FONR N/A
- Revenue Next Year
- IOBT N/A
- FONR N/A
- P/E Ratio
- IOBT N/A
- FONR $12.71
- Revenue Growth
- IOBT N/A
- FONR 1.43
- 52 Week Low
- IOBT $0.66
- FONR $12.00
- 52 Week High
- IOBT $2.79
- FONR $17.98
- Technical
- Relative Strength Index (RSI)
- IOBT 44.35
- FONR 49.26
- Support Level
- IOBT $1.71
- FONR $15.19
- Resistance Level
- IOBT $2.08
- FONR $15.79
- Average True Range (ATR)
- IOBT 0.15
- FONR 0.28
- MACD
- IOBT -0.01
- FONR -0.02
- Stochastic Oscillator
- IOBT 16.36
- FONR 40.51
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.